Cura Technologies is a listed company. Filings by its managers are published through SEBI (PIT + SAST). Between 18 October 2025 and 18 October 2026, 2 insiders published 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 1,986 companies) published 4 filings over the same period, against 2 filings here.
Insider buying of Cura Technologies has been absent for the past year.
These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended March 2026 · cache
2 of 2 declarations
Cura Technologies is a company focused on developing technological solutions for the healthcare sector. It operates in the XBOM market.